Koninklijke Philips (PHIA) | Financial Analysis & Statements

Koninklijke Philips N.V. | Large-cap | Healthcare

€20.61

0.49%

Koninklijke Philips vs Aegon Koninklijke Philips vs Galapagos NV Koninklijke Philips vs Pharming Group N.V Koninklijke Philips vs Avantium N.V Koninklijke Philips vs Vivoryon Koninklijke Philips vs AEX Index | Market

Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 18.0B

Gross Profit 7.8B 43.13%

Operating Income 513.0M 2.85%

Net Income -698.0M -3.87%

EPS (Diluted) -€0.75

Balance Sheet Metrics

Total Assets 29.0B

Total Liabilities 16.9B

Shareholders Equity 12.0B

Debt to Equity 1.41

Cash Flow Metrics

Operating Cash Flow 1.8B

Free Cash Flow 893.0M

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Koninklijke Philips Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue	18.0B	18.2B	17.8B	17.2B	17.3B
Cost of Goods Sold	10.2B	10.7B	10.6B	10.0B	9.5B
Gross Profit	7.8B	7.4B	7.2B	7.2B	7.8B
Operating Expenses	7.3B	7.6B	7.4B	6.5B	6.4B
Operating Income	513.0M	-168.0M	-177.0M	623.0M	1.4B
Pre-tax Income	123.0M	-526.0M	-1.7B	509.0M	1.2B
Income Tax	963.0M	-73.0M	-113.0M	-103.0M	212.0M
Net Income	-698.0M	-463.0M	-1.6B	3.3B	1.2B
EPS (Diluted)	-€0.75	-€0.47	-€1.68	€3.38	€1.19

Income Statement Trend

Koninklijke Philips Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets	10.0B	9.9B	10.3B	10.3B	11.2B
Non-Current Assets	19.0B	19.5B	20.4B	20.6B	16.5B
Total Assets	29.0B	29.4B	30.7B	31.0B	27.7B
Liabilities
Current Liabilities	8.1B	8.3B	7.9B	7.4B	7.7B
Non-Current Liabilities	8.8B	9.1B	9.5B	9.0B	8.1B
Total Liabilities	16.9B	17.3B	17.4B	16.5B	15.8B
Equity
Total Shareholders Equity	12.0B	12.1B	13.3B	14.5B	11.9B

Balance Sheet Composition

Koninklijke Philips Cash Flow Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income	-840.0M	-453.0M	-1.6B	612.0M	999.0M
Operating Cash Flow	1.8B	2.4B	-1.0B	1.9B	2.9B
Investing Activities
Capital Expenditures	13.0M	90.0M	18.0M	33.0M	19.0M
Investing Cash Flow	103.0M	8.0M	-681.0M	-2.9B	-372.0M
Financing Activities
Dividends Paid	-1.0M	-2.0M	-412.0M	-482.0M	-1.0M
Financing Cash Flow	-496.0M	-848.0M	500.0M	-2.3B	483.0M
Free Cash Flow	893.0M	1.5B	-979.0M	866.0M	1.6B

Cash Flow Trend

Koninklijke Philips Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 74.96

Forward P/E 12.49

Price to Book 1.54

Price to Sales 1.00

PEG Ratio 12.49

Profitability Ratios

Profit Margin 2.08%

Operating Margin 3.78%

Return on Equity 1.99%

Return on Assets -2.42%

Financial Health

Current Ratio 1.28

Debt to Equity 64.54

Beta 0.82

Per Share Data

EPS (TTM) €0.26

Book Value per Share €12.64

Revenue per Share €19.33

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
phia	18.0B	74.96	1.54	1.99%	2.08%	64.54
Aegon	9.3B	15.76	1.27	7.17%	5.36%	74.02
Galapagos NV	1.6B	51.71	0.57	-6.36%	-58.83%	0.40
Pharming Group N.V	637.6M	57.15	2.88	-6.78%	-4.40%	55.34
Avantium N.V	113.2M	-35.65	1.17	-43.03%	-127.72%	144.79
Vivoryon	39.2M	-1.85	4.97	-120.41%	0.00%	1.29

Financial data is updated regularly. All figures are in the company's reporting currency.